Skip to main content

Table 1 The characteristics of vaccinated participants and people experienced VH with diabetes

From: The COVID-19 vaccination hesitancy among Chinese individuals with diabetes and the impact on glycemic control of vaccination: a questionnaire study

 

Vaccinated group (n = 131)

VH group (n = 39)

p-value

Gender (male/female)

69/62

13/26

0.044

History of Hypertension (n,%)

69, 52.7%

25, 64.1%

0.271

History of drug allergy (n,%)

32, 24.4%

8, 20.5%

0.673

Autoimmune diseases (n,%)

0, 0%

0, 0%

-

Duration of diabetes (year)

8.2 ± 7.4

8.9 ± 7.7

0.585

Baseline types of glucose lowering drugs (n)

2.1 ± 1.2

2.3 ± 1.2

0.281

Baseline HbA1c (%)

6.56 ± 0.95

7.54 ± 2.01

< 0.001

Baseline FBG (mmol/L)

6.51 ± 1.04

7.13 ± 2.40

0.053

Baseline PBG (mmol/L)

8.32 ± 1.97

9.44 ± 2.94

0.015

  1. FBG Fasting blood glucose, PBG Postprandial blood glucose, glycosylated hemoglobin A1c, HbA1c